Odonate Therapeutics
$31.459876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$31.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.62 (-4.90%) As of 3:11 PM EST today
-$1.62 (-4.90%) Today
Why Robinhood?
You can buy or sell ODT and other stocks, options, ETFs, and crypto commission-free!
About ODT
Odonate Therapeutics, Inc. Common Stock, also called Odonate Therapeutics, is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. Read More It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
Employees
152
Headquarters
San Diego, California
Founded
2013
Market Cap
1.11B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
82.15K
High Today
$33.29
Low Today
$31.09
Open Price
$33.29
Volume
51.03K
52 Week High
$43.75
52 Week Low
$15.25
Collections
ODT Earnings
-$1.24
-$0.83
-$0.41
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.99 per share
Actual
-$0.91 per share
People Also Bought
Editas Medicine
10,088
$22.67
-4.31%Aurora Cannabis
672,362
$1.51
-2.90%Clovis Oncology
5,103
$8.09
-18.45%Viking Therapeutics
39,286
$6.41
-6.15%Hexo
166,375
$1.26
-4.20%Ford
385,493
$7.29
-3.76%Replimune
533
$15.25
-7.74%Fate Therapeutics
1,394
$30.03
-2.09%Progenics Pharmaceuticals
2,066
$5.05
+0.90%Myovant Sciences
5,531
$10.46
-6.36%Sorrento Therapeutics
12,140
$2.27
-5.02%Intellia Therapeutics
5,373